Viral ‘Molecule’ Pill Sparks Health Crisis Among Russian Teens

Moscow– A dangerously addictive weight-loss pill dubbed “Molecule” is surging in popularity among Russian teenagers, fueled by TikTok influencers and black-market sales, leading to a wave of hospitalizations and urgent calls for a nationwide ban.

Promoted as a “miracle” slimming aid, the unregulated capsules—sold for as little as 200 rubles ($2) per pack on Telegram channels—promise rapid fat loss without diet or exercise. Recent lab tests by Russian health authorities have confirmed the pills contain sibutramine, a banned appetite suppressant pulled from global markets in 2010 over links to heart attacks and strokes, alongside unlisted stimulants like caffeine and ephedrine.  Users as young as 14 report severe side effects, including palpitations, nausea, insomnia, and fainting, with emergency room visits among adolescents spiking 30% in major cities like Moscow and St. Petersburg over the past month.
Twenty-two-year-old Maria Ivanovna, a former user from Yekaterinburg, shared her ordeal with the BBC: “I lost 10 kilos in two weeks, but then my heart started racing so fast I blacked out. It’s not worth it—doctors say it could have killed me.” Experts warn the drug’s low cost and viral hype, amplified by influencers flaunting “before-and-after” transformations, exploit body image insecurities amid Russia’s rising youth obesity rates.
Russia’s Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) has launched raids on illicit sellers, seizing thousands of packets, but the underground trade persists. Pediatrician Dr. Elena Petrova told state media: “This is a ticking time bomb for our youth—addiction risks and organ damage could scar a generation.”

As awareness grows, social media campaigns urge teens to #DitchMolecule, but officials say stricter platform regulations are needed to curb the spread. With winter holidays approaching, health advocates fear a fresh surge in misuse.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert